What Researchers Did
Researchers conducted a non-randomized, monocentric, retrospective study to compare visual outcomes in patients with non-arteritic retinal branch artery occlusion treated with hyperbaric oxygen therapy versus hemodilution only.
What They Found
The study found that patients treated with hyperbaric oxygen (HBO) therapy (n=14) achieved a significantly higher final visual acuity of 0.69 ± 0.29 compared to 0.32 ± 0.23 in the control group (n=14) treated with hemodilution only (p = 0.0009). Initial visual acuity was comparable between the HBO group (0.18 ± 0.19) and the control group (0.23 ± 0.19).
What This Means for Canadian Patients
For Canadian patients experiencing non-arteritic retinal branch artery occlusion, hyperbaric oxygen therapy may offer a beneficial treatment option to improve visual outcomes. This could potentially lead to better preservation of vision and quality of life for those affected by this condition.
Canadian Relevance
This study has no direct Canadian connection as it was conducted monocentrically outside of Canada.
Study Limitations
The study's non-randomized, monocentric, and retrospective design limits the generalizability and strength of its findings.